Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case report

Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case report

We report the first successful treatment with the IL-1 receptor antagonist anakinra, in association with the most promising and available antiviral therapy, of a severe case of novel coronavirus disease 2019 (COVID-19). We describe the diagnosis, clinical course, and management of the case, includin...

Full description

Bibliographic Details
Main Authors: Marco Franzetti, Ugo Pozzetti, Manuela Carugati, Alessandro Pandolfo, Chiara Molteni, Paolo Faccioli, Gioacchino Castaldo, Ernesto Longoni, Valentina Ormas, Enrico Iemoli, Stefania Piconi
Format: Article
Language:English
Published: Elsevier 2020-08-01
Series:International Journal of Infectious Diseases
Subjects:
Novel coronavirus disease 2019 (COVID-19)
Cytokine-release syndrome
Interleukin-1 receptor antagonist
Anakinra
Remdesivir
Online Access:http://www.sciencedirect.com/science/article/pii/S120197122030357X

Internet

http://www.sciencedirect.com/science/article/pii/S120197122030357X

Similar Items